VC-backed Akouos debuts IPO
Boston-based Akouos Inc, a precision genetic medicine company, has raised $212.5 million for its IPO after pricing its 12.5 million shares at $17 per share.
Boston-based Akouos Inc, a precision genetic medicine company, has raised $212.5 million for its IPO after pricing its 12.5 million shares at $17 per share.
Copyright PEI Media
Not for publication, email or dissemination